5. What is the cost-benefit ratio of screening for asymptomatic cardiac systolic dysfunction in childhood and young adult cancer survivors? | |||||
---|---|---|---|---|---|
First Author Year |
Study Design | Participants | Diagnostic tests | Main outcomes | Addt’l remarks |
No studies identified |